Latest News
Apr 18, 2019

Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan N.V. (NASDAQ: MYL), today announced a global collaboration to make the experimental drug pretomanid accessible for use in...

Apr 3, 2019

Global pharmaceutical company Mylan N.V. (NASDAQ:MYL) is committed to doing its part to achieve a positive, sustained impact on the world around us, from ensuring responsible operations that...

Mar 18, 2019

Mylan Institutional LLC is conducting a voluntary nationwide recall of two lots (see table below) of Levoleucovorin Injection, 250 mg/25 mL tothe consumer/user level. The lots were manufactured by...

Mar 7, 2019

A small crowd of SBP staff, AmeriCorps members, Puerto Rico Central Office of Recovery and Reconstruction's Omar J. Marrero, Esq and volunteers from global pharmaceutical company Mylan (NASDAQ:...

Feb 28, 2019

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that CFO Ken Parks will present at the Raymond James 40th Annual Institutional Investors Conference in Orlando, Fla., on...

View More

Search News Releases
Contact Mylan Communications

Global Communications 

Stay Connected

Mylan: Seeing is Believing

You are leaving

By clicking Continue below you are leaving and going to a third-party site.